Édition génomique

Lilly’s $1.1B Recombinase Push for Hearing Loss

Eli Lilly has inked an exclusive research and licensing deal with Seamless Therapeutics worth up to $1.12 billion to develop programmable recombinase gene-editing therapies for in… Jan 28, 2026

Technology

Farming Rebooted: Tech's Next Harvest

From soil microbes to AI-driven maps, a wave of agritech aims to boost yields, cut emissions and reshape who grows our food. This article maps the technologies, economics and risk… Jan 21, 2026

Genetics

One‑Shot Gene Editor Targets Nonsense Mutations

A new gene‑editing platform called PERT uses engineered suppressor tRNA to bypass premature stop signals in DNA, rescuing protein production in cells and mice and offering a poten… Déc 05, 2025

Genetics

Curing All Genetic Diseases in a Decade?

A Mammoth Biosciences executive told the Dubai Future Forum that gene editing could treat every genetic disease within ten years. Here’s what the science, recent trials and major … Nov 19, 2025

édition génomique

Articles about édition génomique

Lilly’s $1.1B Recombinase Push for Hearing Loss

Farming Rebooted: Tech's Next Harvest

One‑Shot Gene Editor Targets Nonsense Mutations

Curing All Genetic Diseases in a Decade?